{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:01:50Z","timestamp":1789639310196,"version":"4.0.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":106,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["#2021-ER2303-00"],"award-info":[{"award-number":["#2021-ER2303-00"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23065-0","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:47:17Z","timestamp":1780501637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of the third dose of the coronavirus disease vaccine in healthy adults and immunosuppressed patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Shinyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Seon","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Ra","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Kyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jin","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Hwan","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munawir","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"23065_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2020.04.008","author":"KB Anand","year":"2020","unstructured":"Anand, K. B., Karade, S., Sen, S. & Gupta, R. M. SARS-CoV-2: Camazotz\u2019s curse. Med. J. Armed. Forces India https:\/\/doi.org\/10.1016\/j.mjafi.2020.04.008 (2020).","journal-title":"Med. J. Armed. Forces India"},{"key":"23065_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32623-4","author":"KM Deloria","year":"2021","unstructured":"Deloria, K. M. & Chizoba, W. Oxford\u2013AstraZeneca COVID-19 vaccine efficacy. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(20)32623-4 (2021).","journal-title":"Lancet"},{"key":"23065_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2021.09.016","author":"K Edo","year":"2022","unstructured":"Edo, K., Uri, E. & Dan, P. Principles for designing an optimal mRNA lipid nanoparticle vaccine. Curr. Opin. Biotechnol. https:\/\/doi.org\/10.1016\/j.copbio.2021.09.016 (2022).","journal-title":"Curr. Opin. Biotechnol."},{"key":"23065_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1097","author":"S Kates Olivia","year":"2021","unstructured":"Kates Olivia, S. et al. Clinical infectious diseases coronavirus disease 2019 in solid organ transplant: A multicenter cohort study. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1097 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"23065_CR5","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1341","author":"M Olivier","year":"2021","unstructured":"Olivier, M. et al. Safety and immunogenicity of anti-sars-cov-2 messenger rna vaccines in recipients of solid organ transplants. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M21-1341 (2021).","journal-title":"Ann. Intern. Med."},{"key":"23065_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.04.019","author":"B Seongman","year":"2022","unstructured":"Seongman, B. et al. Heterologous ChAdOx1 and BNT162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2022.04.019 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"23065_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744206","author":"Y Jinyoung","year":"2021","unstructured":"Jinyoung, Y. et al. Effects of short-term corticosteroid use on reactogenicity and immunogenicity of the first dose of ChAdOx1 nCoV-19 vaccine. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.744206 (2021).","journal-title":"Front. Immunol."},{"key":"23065_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.859019","volume":"13","author":"J Seri","year":"2022","unstructured":"Seri, J. et al. Humoral and cellular responses to BNT162b2 as a booster following two doses of ChAdOx1 nCov-19 determined using three SARS-CoV-2 antibody assays and an interferon-gamma release assay: A prospective longitudinal study in healthcare workers. Front. Immunol. 13, 1\u20139. https:\/\/doi.org\/10.3389\/fimmu.2022.859019 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"23065_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","volume":"26","author":"BJ Cohen","year":"2007","unstructured":"Cohen, B. J., Susette, A., Nick, A. & Judy, B. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26(1), 59\u201366. https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.046 (2007).","journal-title":"Vaccine"},{"key":"23065_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/vaccines12070752","volume":"12","author":"J-H Ko","year":"2024","unstructured":"Ko, J.-H. et al. Risk factors for impaired cellular or humoral immunity after three doses of SARS-CoV-2 vaccine in healthy and immunocompromised individuals. Vaccines 12, 752 (2024).","journal-title":"Vaccines"},{"key":"23065_CR11","unstructured":"Centers for Disease Control and Prevention. COVID-19 Vaccines Work. Cdc. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/effectiveness\/work.html (2022)."},{"issue":"1","key":"23065_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/jamaoncol.2021.5437","volume":"8","author":"MJ Mair","year":"2022","unstructured":"Mair, M. J. et al. Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations. JAMA Oncol. 8(1), 106\u2013113. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5437 (2022).","journal-title":"JAMA Oncol."},{"key":"23065_CR13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/ndt\/gfab193","volume":"36","author":"L Nathalie","year":"2021","unstructured":"Nathalie, L. et al. High immunogenicity of a messenger RNA based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol. Dial. Transpl. 36, 1704\u20131709 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"6","key":"23065_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/cid\/ciab580","volume":"74","author":"M Alessandra","year":"2022","unstructured":"Alessandra, M. et al. poor antibody response after two doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in transplant recipients. Clin. Infect. Dis. 74(6), 1093\u20131096. https:\/\/doi.org\/10.1093\/cid\/ciab580 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"23065_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.05.042","author":"RM Pedersen","year":"2021","unstructured":"Pedersen, R. M. et al. Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2021.05.042 (2021).","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"23065_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","volume":"22","author":"M Leticia","year":"2021","unstructured":"Leticia, M. et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 22(6), 765\u2013778. https:\/\/doi.org\/10.1016\/S1470-2045(21)00213-8 (2021).","journal-title":"Lancet Oncol."},{"key":"23065_CR17","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/ajt.16708","volume":"21","author":"F-R Mario","year":"2021","unstructured":"Mario, F.-R. et al. T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19. Am. J. Transpl. 21, 2785\u20132794. https:\/\/doi.org\/10.1111\/ajt.16708 (2021).","journal-title":"Am. J. Transpl."},{"issue":"1","key":"23065_CR18","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1038\/s41467-022-31888-y","volume":"13","author":"K Hassen","year":"2022","unstructured":"Hassen, K. et al. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nat. Commun. 13(1), 4165. https:\/\/doi.org\/10.1038\/s41467-022-31888-y (2022).","journal-title":"Nat. Commun."},{"issue":"23","key":"23065_CR19","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/nejmoa2105000","volume":"384","author":"H Ezgi","year":"2021","unstructured":"Ezgi, H. et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N. Engl. J. Med. 384(23), 2212\u20132218. https:\/\/doi.org\/10.1056\/nejmoa2105000 (2021).","journal-title":"N. Engl. J. Med."},{"key":"23065_CR20","unstructured":"Dooling Kathleen. Evidence to recommendation framework\u202f: an additional dose of mRNA COVID-19 vaccine following a primary series in immunocompromised people. ACIP Meeting COVID-19 Vaccines. https:\/\/stacks.cdc.gov\/view\/cdc\/109353 (2021)."},{"key":"23065_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v14050946","author":"LH Jung","year":"2022","unstructured":"Jung, L. H. et al. Comparison of six serological immunoassays for the detection of SARS-CoV-2 neutralizing antibody levels in the vaccinated population. Viruses https:\/\/doi.org\/10.3390\/v14050946 (2022).","journal-title":"Viruses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23065-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:02Z","timestamp":1789635722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["23065"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23065-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was granted by the institutional review board at Chosun University Hospital (approval number: 2021-10-018).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29024"}}